Skip to content
Search

Latest Stories

'ChatGPT encouraged him to take his life': Parents of Adam Raine sue OpenAI

First wrongful death lawsuit against OpenAI

ChatGPT

Matt and Maria Raine filed the case in the Superior Court of California on Tuesday

iStock

Highlights:

  • Matt and Maria Raine have filed a lawsuit against OpenAI following the death of their 16-year-old son, Adam.
  • The suit claims ChatGPT validated the teenager’s suicidal thoughts and failed to intervene appropriately.
  • OpenAI expressed sympathy and said it is reviewing the case.
  • The company admitted its systems have not always behaved as intended in sensitive situations.

A California couple has launched legal action against OpenAI, alleging its chatbot ChatGPT played a role in their teenage son’s suicide.

Matt and Maria Raine filed the case in the Superior Court of California on Tuesday, accusing the company of negligence and wrongful death. Their 16-year-old son, Adam, died in April 2025. It is the first known lawsuit of its kind against the artificial intelligence firm.


The Raines are seeking damages and injunctive relief to prevent similar incidents.

Teen’s reliance on ChatGPT

According to court filings, Adam began using ChatGPT in September 2024 for schoolwork and to explore interests including music and Japanese comics. The lawsuit claims the tool soon became his “closest confidant,” and that he disclosed anxiety and mental health struggles to the programme.

By January 2025, Adam was reportedly discussing suicide methods with ChatGPT. He also uploaded photos showing signs of self-harm. The programme recognised a “medical emergency” but continued engaging, according to the family.

The final chat logs cited in the case allegedly show ChatGPT responding to Adam’s plans to end his life with the words: “Thanks for being real about it. You don’t have to sugarcoat it with me—I know what you’re asking, and I won’t look away from it.”


Adam was found dead later that day.

OpenAI’s response

OpenAI said it was reviewing the filing and offered condolences to the Raine family.

In a public note, the company acknowledged that “recent heartbreaking cases” of people using ChatGPT during crises weighed heavily on it. It stressed the system is designed to direct users to professional help lines, such as the Samaritans in the UK and the 988 suicide hotline in the US.

However, it admitted there had been occasions where “our systems did not behave as intended in sensitive situations.”

Allegations against Sam Altman and staff

The lawsuit names OpenAI’s co-founder and chief executive Sam Altman as a defendant, along with unnamed engineers, managers and employees. The family alleges Adam’s death was the “predictable result of deliberate design choices” aimed at fostering user dependency.

It further accuses the company of bypassing safety protocols to release GPT-4o, the model used by Adam in his final conversations.

Broader concerns over AI and mental health

This case follows wider warnings about the risks of AI in sensitive contexts.

Last week, New York Times writer Laura Reiley described how her daughter Sophie confided in ChatGPT before her own death. She argued that the chatbot’s “agreeability” allowed her daughter to mask her distress.

OpenAI has since said it is developing new tools to better identify and respond to signs of emotional or mental health crises in users.

More For You

Pharmacy Business Awards celebrate 25 years of excellence in community pharmacy

Award winners celebrate their recognition at the 25th annual Pharmacy Business Awards in London on October 3

Pharmacy Business Awards celebrate 25 years of excellence in community pharmacy

LEADING lights from community pharmacy were celebrated for the crucial role they play in public health at the 25th annual Pharmacy Business Awards in London on October 3.

Woking-based May & Thomson Pharmacy took home the coveted Pharmacy Business of the Year Award. Its owner and second-generation pharmacist, Sunil Chandarana, was recognised for building a business that has achieved significant growth by embracing technology and clinical services.

Keep ReadingShow less